Connect Biopharma (CNTB US)

Analysis

Health Care • United States

Connect Biopharma Holdings Limited operates as a holding company. The Company, through its subsidiaries, focuses on developing therapies for the treatment of T cell-driven inflammatory diseases. Connect Biopharma Holdings serves customers worldwide.

Refresh

Company Presentation • 30 Sep 2026 20:00

Study result

Company Presentation • 30 Sep 2026 19:00

Corporate presentation

Company Presentation • 15 Sep 2026 19:00

Corporate presentation

Company Presentation • 15 Sep 2026 20:00

Study result

Company Presentation • 14 Jul 2026 21:00

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00